Administration of finerenone in chronic kidney disease

• Main Authors: Mohsen Akhavan Sepahi (Author), Elham Emami (Author), Akshaya Ann Joseph (Author), Shakiba Hassanzadeh (Author), Mohammad Reza Razavi (Author)
• Format: Book
• Published: Society of Diabetic Nephropathy Prevention, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Spironolactone is a first-generation and non-selective mineralocorticoid receptor antagonist (MRA). It is extensively well-studied and recommended due to increased accessibility for patients. Unfortunately, it is often discontinued in several cases due to its association with hyperkalemia. The appar...